USPTO serial 79182923
WISTA
Reviewed by CopyMark Law Group
Reg. 5153172Status 404
- Filing date
- Status date
- Registration date
- Mar 7, 2017
- Examiner
- BAGLINI, KAREN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with WISTA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Singapore 658066, SG
Singapore 658066, SG
SG
Singapore 658066, SG
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Thad Chaloemtiarana
Thad Chaloemtiarana Pattishall, McAuliffe, Newbury, Hilliard200 South Wacker Drive, Suite 2900Chicago, IL 60606-5896UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and medical preparations for use in the detection, prevention and treatment of neurological diseases and disorders, neurodegenerative diseases and disorders, blood disorders, infectious diseases and malaria; chemical preparations for medical and pharmaceutical purposes for use in the detection, prevention and treatment of neurological diseases and disorders, neurodegenerative diseases and disorders, blood disorders, infectious diseases and malaria; none of the aforesaid being pharmaceutical preparations and substances intended for the prevention and treatment of bone/skeletal diseases | SECTION 71 - CANCELLED | — |
| 042 | Medical, biological, biotechnological, genetic, and pharmaceutical research, design and development services and laboratory research services in the fields of drugs, pharmaceuticals and medicines; research, development and design of drugs and medicine; drug discovery services; laboratory and medical laboratory research and development services relating to drugs, pharmaceuticals and medicines; exploitation of scientific research and technology, namely, providing advice and information relating to scientific and technological research in the fields of drugs, pharmaceuticals and medicines, and in the fields of drug development, clinical trial design, patient recruitment, drug testing, clinical data management, data analysis, statistical analysis, patient selection, clinical diagnosis and diagnostic testing; researching and developing new products in the fields of drugs, pharmaceuticals and medicines; scientific research and development services in the fields of drug development, clinical trial design, patient recruitment, drug testing, clinical data management, data analysis, statistical analysis, patient selection, clinical diagnosis and diagnostic testing; preparation of reports of scientific and medical research concerning drugs, pharmaceuticals, medicines, genetics, biology and biotechnology; development and design of medical or scientific prognostic and diagnostic apparatus and instruments; consultancy and information services relating to all of the aforesaid | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by WisTa Laboratories Ltd
- Other trademarks owned by WisTa Laboratories Ltd
- Other trademarks owned by TauRx Therapeutics Ltd.
- Other trademarks owned by WisTa Laboratories Ltd
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named WISTA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 6, 2026 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Aug 6, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Nov 20, 2025 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jul 14, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 24, 2024 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 24, 2024 | INPC | INVALIDATION PROCESSED | — |
| Jun 14, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 22, 2023 | C71T | CANCELLED SECTION 71 | — |
| Mar 7, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 8, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 19, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 19, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 7, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 7, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 20, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 20, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 30, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 16, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 5, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 3, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 3, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 3, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 6, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 6, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 6, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 15, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 15, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 10, 2016 | ALIE | ASSIGNED TO LIE | — |
| Sep 2, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 13, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 15, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 15, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 15, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 14, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 11, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 27, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 23, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 22, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |